propidium has been researched along with lovastatin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Granberry, MC; Kennedy, RH; Liu, H; Melchert, RB | 1 |
Kong, JY; Rabkin, SW | 1 |
2 other study(ies) available for propidium and lovastatin
Article | Year |
---|---|
Lovastatin inhibits phenylephrine-induced ERK activation and growth of cardiac.
Topics: Animals; Animals, Newborn; Anticholesteremic Agents; Blotting, Western; Cardiomegaly; Cells, Cultured; Coloring Agents; Enzyme Activation; Heart; Lovastatin; Mitogen-Activated Protein Kinases; Myocardium; Phenylephrine; Phosphorylation; Pravastatin; Propidium; Rats; Rats, Sprague-Dawley; Tetrazolium Salts; Thiazoles | 2001 |
Lovastatin-induced cardiac toxicity involves both oncotic and apoptotic cell death with the apoptotic component blunted by both caspase-2 and caspase-3 inhibitors.
Topics: Animals; Apoptosis; Caspase 2; Caspase 3; Caspase Inhibitors; Cells, Cultured; Chick Embryo; Cysteine Proteinase Inhibitors; DNA; Flow Cytometry; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Lovastatin; Microscopy, Fluorescence; Myocytes, Cardiac; Propidium | 2003 |